Randomized Phase II Trial of Intralesional Lymphokine Activated Killer Cells or Polifeprosan 20 With Carmustine Implant (Gliadel Wafer) as Consolidation Therapy After Primary Treatment of Newly Diagnosed Resectable Glioblastoma
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2013
At a glance
- Drugs Carmustine polifeprosan 20 wafer (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 03 Jun 2009 New trial record.